UK Liver Diseases Therapeutics Market Analysis

UK Liver Diseases Therapeutics Market Analysis


$ 3999

By 2030, it is anticipated that the UK Liver Disease Therapeutics market will reach a value of $803 Mn from $600 Mn in 2022, growing at a CAGR of 3.7% during 2022-2030. Liver Disease Therapeutics in the UK is dominated by a few domestic pharmaceutical companies such as Intercept Pharmaceuticals, Gilead Sciences, AstraZeneca and Shire. The Liver Disease Therapeutics market in the UK is segmented into different types of disease and different therapy types. Some of the major factors affecting the UK Liver Disease Therapeutics market are the growing prevalence of liver diseases and unhealthy and dynamic lifestyles.

ID: IN10GBPH040 CATEGORY: Pharmaceuticals GEOGRAPHY: UK AUTHOR: Dr. Vishwa Modhia

Buy Now

UK Liver Disease Therapeutics Analysis Summary

By 2030, it is anticipated that the UK Liver Disease Therapeutics market will reach a value of $803 Mn from $600 Mn in 2022, growing at a CAGR of 3.7% during 2022-2030.

The UK is a high-income, developed island country spanning an archipelago including Great Britain, located in Western Europe comprising England, Scotland, Wales, and Northern Ireland. Liver disease is the fifth leading cause of mortality in the United Kingdom and the only major cause of death that is on the rise. According to the most recent WHO data, 7,666 people died from liver disease in the United Kingdom in 2020, accounting for 1.50 % of all deaths.

With an age-adjusted death rate of 7.90 per 100,000 inhabitants, the United Kingdom ranks 142nd in the world. 90% of liver disease in the UK is caused by alcohol, obesity, and viral hepatitis, and is thus preventable. Every year, approximately 1000 liver transplants are performed. At any given time, 350 patients are waiting for a liver transplant. UK's government spends 12 % of its GDP on healthcare.

UK Liver Disease Therapeutics Analysis

Market Dynamics

Market Growth Drivers Analysis

In the United Kingdom, the prevalence of liver illnesses is rising. 63 % of UK adults are now classified as obese or overweight, and one in every three has the early-stage non-alcohol-related fatty liver disease (NAFLD). Viral hepatitis affects approximately 215,000 persons in the United Kingdom, with approximately half of these cases going untreated. Pharmaceuticals is a cutting-edge industry in the United Kingdom. These aspects could boost the UK Liver Disease Therapeutics market.

Market Restraints

People from lower socioeconomic origins are disproportionately affected by the liver disease because they are more prone to engage in risky behaviours such as heavy alcohol intake and bad diets. Low productivity and a lack of training in the United Kingdom are not conducive to innovation. While developing new pharmaceuticals and cures, it is necessary to follow regulatory rules established by organisations such as the UK's Medicines and Healthcare products Regulatory Agency (MHRA). These criteria can be complicated and time-consuming, resulting in delays and higher expenses. These factors may deter new entrants into the UK Liver Disease Therapeutics market.

Competitive Landscape

Key Players

  • Gilead Sciences: Gilead Sciences is a leading biopharmaceutical company that specializes in the development of innovative treatments for liver diseases such as hepatitis B and C, liver cancer, and non-alcoholic steatohepatitis (NASH)
  • Intercept Pharmaceuticals: Intercept Pharmaceuticals is a biopharmaceutical company that focuses on the development of therapeutics for chronic liver diseases such as primary biliary cholangitis (PBC) and NASH
  • AstraZeneca: AstraZeneca is a global pharmaceutical company that develops and markets drugs for various diseases including liver diseases such as primary sclerosing cholangitis (PSC) and NASH
  • GlaxoSmithKline: GlaxoSmithKline is a global healthcare company that focuses on the development of innovative treatments for liver diseases such as hepatitis B and C
  • Shire: Shire is a biotechnology company that develops and markets treatments for rare diseases, including rare liver diseases such as hereditary angioedema and Wilson's disease
  • Merck Sharp & Dohme: Merck Sharp & Dohme is a global pharmaceutical company that develops and markets drugs for various diseases including liver diseases such as hepatitis C and NASH
  • AbbVie: AbbVie is a biopharmaceutical company that focuses on the development of innovative treatments for liver diseases such as hepatitis C and NASH

Recent Notable Updates

January 2023: Intercept Pharmaceuticals, a biopharmaceutical company, said that the FDA has approved Intercept's New Drug Application (NDA) for obeticholic acid (OCA), which seeks fast clearance for the treatment of patients with pre-cirrhotic liver fibrosis caused by non-alcoholic steatohepatitis (NASH). The FDA stated that this is a comprehensive Class 2 resubmission and has assigned the NDA a Prescription Drug User Fee Act (PDUFA) target action date of June 2023. The FDA's schedule for reviewing the NDA is still open to change.

Healthcare Policies and Reimbursement Scenarios

In the UK, liver disease therapeutics are regulated by the Medicines and Healthcare products Regulatory Agency (MHRA), which is responsible for ensuring the safety, quality, and efficacy of medicines. The MHRA evaluates the clinical data on new drugs and decides whether to approve them for use in the UK market. The National Institute for Health and Care Excellence (NICE) is responsible for evaluating the cost-effectiveness of new drugs and making recommendations to the NHS on whether to reimburse them.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Liver Disease Therapeutics Segmentation

By Treatment Type (Revenue, USD Billion):

  • Chemotherapy
  • Antiviral Drugs
  • Vaccines
  • Immunosuppressants
  • Corticosteroids
  • Immunoglobulins
  • Targeted Therapy

By Disease Type (Revenue, USD Billion):

  • Non-alcoholic Fatty Liver Disease (NAFLD)
  • Autoimmune Diseases
  • Cancer
  • Hepatitis
  • Genetic Disorder
  • Others

By Distribution Channel (Revenue, USD Billion):

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

 

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

 

 

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

 

 

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 20 March 2023
Updated by: Riya Doshi

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up